Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioceres Crop Solutions (BIOX) Operating Expenses (2016 - 2026)

Bioceres Crop Solutions' Operating Expenses history spans 5 years, with the latest figure at -$18.0 million for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 15.49% to -$18.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$39.3 million, a 405.21% decrease, with the full-year FY2025 number at $144.0 million, down 1.79% from a year prior.
  • Operating Expenses hit -$18.0 million in Q1 2026 for Bioceres Crop Solutions, up from -$21.3 million in the prior quarter.
  • Over the last five years, Operating Expenses for BIOX hit a ceiling of $13.5 million in Q2 2022 and a floor of -$21.3 million in Q1 2025.
  • Historically, Operating Expenses has averaged -$8.6 million across 3 years, with a median of -$18.0 million in 2026.
  • Biggest five-year swings in Operating Expenses: soared 33.55% in 2022 and later grew 15.49% in 2026.
  • Tracing BIOX's Operating Expenses over 3 years: stood at $13.5 million in 2022, then tumbled by 257.53% to -$21.3 million in 2025, then rose by 15.49% to -$18.0 million in 2026.
  • Business Quant data shows Operating Expenses for BIOX at -$18.0 million in Q1 2026, -$21.3 million in Q1 2025, and $13.5 million in Q2 2022.